EV/EBITDA:
-14.63+0.21(+1.42%)Summary
- As of today (August 3, 2025), CGON EV/EBITDA is -14.63, with a rise of +0.21 (+1.42%) during the most recent trading session on August 1, 2025.
- Over the past year, CGON EV/EBITDA has increased by +12.68 (+46.43%).
- CGON EV/EBITDA is now -71.31% below its all-time high of -8.54.
Performance
CGON EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CGON EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.4% | -1.4% | -1.4% |
| 1 m1 month | +0.1% | -0.1% | -0.1% |
| 3 m3 months | +5.3% | -5.3% | -5.2% |
| 6 m6 months | +17.5% | -3.4% | -12.5% |
| ytdytd | +13.0% | +2.0% | -8.3% |
| 1 y1 year | +46.4% | -11.9% | -22.3% |
| 5 y5 years | - | - | - |
CGON EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -13.85 | -5.6% | -15.85 | +7.7% |
| 3 m | 3-month | -12.01 | -21.8% | -16.18 | +9.6% |
| 6 m | 6-month | -8.54 | -71.3% | -17.90 | +18.3% |
| 1 y | 1-year | -8.54 | -71.3% | -31.81 | +54.0% |
| 3 y | 3-year | -8.54 | -71.3% | -57.35 | +74.5% |
| 5 y | 5-year | -8.54 | -71.3% | -57.35 | +74.5% |
| alltime | all time | -8.54 | -71.3% | -57.35 | +74.5% |
CGON EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -14.63(-13.0%) |
| Date | Value |
|---|---|
| 2024 | -16.81 |
FAQ
- What is CG Oncology, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for CG Oncology, Inc.?
- What is CGON EV/EBITDA year-to-date change?
- What is CG Oncology, Inc. EV/EBITDA year-on-year change?
What is CG Oncology, Inc. EV/EBITDA?
The current EV/EBITDA of CGON is -14.63
What is the all time high EV/EBITDA for CG Oncology, Inc.?
CG Oncology, Inc. all-time high EV/EBITDA is -8.54
What is CGON EV/EBITDA year-to-date change?
CG Oncology, Inc. EV/EBITDA has changed by +2.18 (+12.97%) since the beginning of the year
What is CG Oncology, Inc. EV/EBITDA year-on-year change?
Over the past year, CGON EV/EBITDA has changed by +12.68 (+46.43%)